Table 1.
Baseline data in the whole cohort and comparison of both groups
| Variables | Whole cohort n = 308 | Group LVT (+) n = 36 (11.7%) | Group LVT (−) n = 272 (88.3%) | P value |
|---|---|---|---|---|
| I Clinical data | ||||
| Age, y | 56 ± 10 | 55 ± 10 | 56 ± 11 | NS |
| Male gender, n (%) | 257 (83) | 33 (92) | 224 (82) | NS |
| Race, n (%) | ||||
| Asian | 276 (90) | 33 (92) | 243 (89) | NS |
| African | 32 (10) | 3 (8) | 29 (11) | NS |
| Pilgrim patient | 81 (26) | 7 (19) | 74 (27) | NS |
| Obesity, n (%) | 208 (67) | 27 (75) | 181 (66) | NS |
| Hypertension, n (%) | 144 (47) | 17 (47) | 127 (47) | NS |
| Diabetes, n (%) | 167 (54) | 19 (53) | 148 (54) | NS |
| Dyslipidemia, n (%) | 45 (15) | 6 (17) | 39 (14) | NS |
| History of CAD, n (%) | 27 (9) | 2 (6) | 25 (9) | NS |
| Killip class IV, n (%) | 8 (2.6) | 0 | 8 (3) | NS |
| Peri PPCI CPR, n (%) | 11 (3.6) | 1 (3) | 10 (4) | NS |
| Peri PPCI IABP, n (%) | 21 (7) | 7 (19) | 14 (5) | NS |
| IIb/IIIa inhibitor, n (%) | 99 (32) | 16 (44) | 83 (31) | NS |
| Inotropes, n (%) | 33 (11) | 4 (11) | 29 (11) | NS |
| II Electrocardiographic data | ||||
| Anterior STEMI, n (%) | 171 (55.5) | 34 (94.4) | 137 (50) | < 0.0001 |
| Nonanterior STEMI, n (%) | 137 (44.5) | 2 (6) | 135 (50) | < 0.0001 |
| III Laboratory data | ||||
| Peak troponin (ng/mL) | 161 ± 276 | 204 ± 49 | 155 ± 18 | NS |
| Creatinine (mg/dL) | 1.3 ± 1.2 | 1.6 ± 0.2 | 1.3 ± 0.1 | NS |
| Protein (g/dL) | 6.5 ± 1.1 | 6.7 ± 0.4 | 6.5 ± 0.2 | NS |
| Platelet count (platelet/μL) | 255 ± 92 | 271 ± 16 | 252 ± 6 | NS |
| Haemoglobin (g/dL) | 14 ± 2 | 14 ± 0.3 | 14 ± 0.1 | NS |
| Hematocrit (%) | 38 ± 6 | 38.2 ± 2.7 | 38.0 ± 7 | NS |
CAD, coronary artery disease; CPR, cardiopulmonary resuscitation; IABP, intra-aortic balloon pump; LVT, left ventricular thrombus; NS, not significant; PPCI, primary percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction.